Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Clindamycin + Oral Metronidazole for Bacterial Vaginosis
NCT07247851Completed
- Sponsor
- Ain Shams University Maternity Hospital
- Start
- Jan 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of clindamycin in bacterial vaginosis (BV) (2 arms), sponsored by Ain Shams University Maternity Hospital. Primary endpoint: Bacterial Vaginosis Treatment Success at 6 months. Started Jan 2024; status: completed.
02
Drugs
clindamycin
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT07247851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07247851.